256 related articles for article (PubMed ID: 2127400)
1. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.
Chaouloff F; Laude D; Baudrie V
Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms involved in the hyperglycemic effect of the 5-HT1C/5-HT2 receptor agonist, DOI.
Baudrie V; Chaouloff F
Eur J Pharmacol; 1992 Mar; 213(1):41-6. PubMed ID: 1499656
[TBL] [Abstract][Full Text] [Related]
3. Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat.
Chaouche-Teyara K; Fournier B; Safar M; Dabiré H
Eur J Pharmacol; 1993 Nov; 250(1):67-75. PubMed ID: 7907025
[TBL] [Abstract][Full Text] [Related]
4. Effects of the 5-HT2C/2B receptor agonist 1-(3-chlorophenyl) piperazine on plasma glucose levels of rats.
Sugimoto Y; Yamada J; Yoshikawa T; Horisaka K
Eur J Pharmacol; 1996 Jun; 307(1):75-80. PubMed ID: 8831107
[TBL] [Abstract][Full Text] [Related]
5. (+/-)-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane(DOI) and alpha-methyl-5-HT: 5-HT2 receptor agonistic action on phosphatidylinositol metabolism in the rat fronto-cingulate and entorhinal cortex.
Edwards E; Ashby CR; Wang RY
Neuropharmacology; 1992 Jul; 31(7):615-21. PubMed ID: 1407401
[TBL] [Abstract][Full Text] [Related]
6. Central 5-hydroxytryptamine2 receptors are involved in the adrenal catecholamine-releasing and hyperglycemic effects of the 5-hydroxytryptamine indirect agonist d-fenfluramine in the conscious rat.
Chaouloff F; Gunn SH; Young JB
J Pharmacol Exp Ther; 1992 Mar; 260(3):1008-16. PubMed ID: 1545373
[TBL] [Abstract][Full Text] [Related]
7. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
Berendsen HH; Broekkamp CL
Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180
[TBL] [Abstract][Full Text] [Related]
8. 5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats.
Jenck F; Broekkamp CL; Van Delft AM
Psychopharmacology (Berl); 1990; 100(3):372-6. PubMed ID: 2107558
[TBL] [Abstract][Full Text] [Related]
9. 5-HT1C/5-HT2 receptor blockade prevents 1-(2,5-dimethoxy-4-iodophenyl)2-aminopropane-, but not stress-induced increases in brain tryptophan.
Chaouloff F; Layeillon C; Baudrie V
Eur J Pharmacol; 1993 Jan; 231(1):77-82. PubMed ID: 8095238
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
Albinsson A; Palazidou E; Stephenson J; Andersson G
Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
[TBL] [Abstract][Full Text] [Related]
11. Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors.
Rittenhouse PA; Bakkum EA; Van de Kar LD
J Pharmacol Exp Ther; 1991 Oct; 259(1):58-65. PubMed ID: 1920135
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats.
Fone KC; Robinson AJ; Marsden CA
Br J Pharmacol; 1991 Jun; 103(2):1547-55. PubMed ID: 1832068
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
Bagdy G; Sved AF; Murphy DL; Szemeredi K
Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
[TBL] [Abstract][Full Text] [Related]
14. The selective 5-HT2 receptor antagonist amperozide attenuates 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane-induced inhibition of male rat sexual behavior.
Klint T; Dahlgren IL; Larsson K
Eur J Pharmacol; 1992 Mar; 212(2-3):241-6. PubMed ID: 1601066
[TBL] [Abstract][Full Text] [Related]
15. Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors.
Kennett GA; Curzon G
Psychopharmacology (Berl); 1988; 96(1):93-100. PubMed ID: 2906446
[TBL] [Abstract][Full Text] [Related]
16. Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.
Kennett GA; Curzon G
Br J Pharmacol; 1988 May; 94(1):137-47. PubMed ID: 3401632
[TBL] [Abstract][Full Text] [Related]
17. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat.
Bervoets K; Millan MJ; Colpaert FC
Eur J Pharmacol; 1990 Nov; 191(2):185-95. PubMed ID: 2150818
[TBL] [Abstract][Full Text] [Related]
18. Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo.
Done CJ; Sharp T
Br J Pharmacol; 1992 Sep; 107(1):240-5. PubMed ID: 1422575
[TBL] [Abstract][Full Text] [Related]
19. Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HT1c/2 receptors.
Rittenhouse PA; Levy AD; Li Q; Bethea CL; Van de Kar LD
Endocrinology; 1993 Aug; 133(2):661-7. PubMed ID: 8344205
[TBL] [Abstract][Full Text] [Related]
20. Subchronic treatment with anxiolytic doses of the 5-HT1A receptor agonist ipsapirone does not affect 5-HT2 receptor sensitivity in the rat.
Baudrie V; De Vry J; Broqua P; Schmidt B; Chaouloff F; Glaser T
Eur J Pharmacol; 1993 Feb; 231(3):395-406. PubMed ID: 8095465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
